CervoMed
(NASDAQ) CRVO
CervoMed Financials at a Glance
Market Cap
$36.76M
Revenue (TTM)
$322.57K
Net Income (TTM)
$26.97M
EPS (TTM)
$-2.97
P/E Ratio
-1.34
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$3.93
Volume
440
Open
$3.87
Price
$3.93
Volume
440
Open
$3.87
Previous Close
$3.93
Daily Range
$3.86 - $4.01
52-Week Range
$3.51 - $13.13
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$3.93
Volume
440
Open
$3.87
Previous Close
$3.93
Daily Range
$3.86 - $4.01
52-Week Range
$3.51 - $13.13
CRVO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CervoMed
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
John J. Alam, MD
Website
www.cervomed.comHeadquarters
Boston, MA 02116, US
CRVO Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-88%
Net Income Margin
-84%
Return on Equity
-94%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-74.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$36.76M
Shares Outstanding
9.26M
Volume
440
Short Interest
0.00%
Avg. Volume
80.01K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$28.29M
EBITDA
$28.29M
Operating Cash Flow
$23.45M
Capital Expenditure
$0.00
Free Cash Flow
$23.45M
Cash & ST Invst.
$20.86M
Total Debt
$0.00
CervoMed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$36.76M
N/A
Market Cap/Employee
$2.45M
N/A
Employees
15
N/A
Net Income
$8.09M
-20.6%
EBITDA
$8.33M
-15.1%
Quarterly Fundamentals
Net Cash
$20.86M
-46.4%
Accounts Receivable
$426.99K
-81.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.15%
N/A
Return on Invested Capital
-1.51%
N/A
Free Cash Flow
$6.58M
+18.3%
Operating Cash Flow
$6.58M
+18.3%